agreed. But being able to sell high-efficacy products to deal...

agreed. But being able to sell high-efficacy products to deal with Covid Heath management represent a huge opportunity for AEI to get their foot in the door and their name out in the market.

basically the last year has been a massive accelerator for company growth. I’d only give them a 6/10 for their management of the opportunity based on missing a huge window of opportunity from June-Dec 2020 because US EPA approval was delayed.

I think they’ll still grow the company significantly in the next few years but it will be slower without that US kickstart